Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

T. Hinks (Oxford, United Kingdom), B. Hilvering (Utrecht, Netherlands), L. Stoger (Oxford, United Kingdom), E. Marchi (Oxford, United Kingdom), M. Salimi (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), W. Lu (Oxford, United Kingdom), W. Chen (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), S. Go (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Kurioka (Oxford, United Kingdom), T. Leng (Oxford, United Kingdom), J. Matthews (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Willberg (Oxford, United Kingdom), A. Ramasamy (Oxford, United Kingdom), R. Djukanovic (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom)

Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Session: Advanced profiling of immune cells in chronic lung diseases
Session type: Oral Presentation
Number: 4927
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Hinks (Oxford, United Kingdom), B. Hilvering (Utrecht, Netherlands), L. Stoger (Oxford, United Kingdom), E. Marchi (Oxford, United Kingdom), M. Salimi (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), W. Lu (Oxford, United Kingdom), W. Chen (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), S. Go (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Kurioka (Oxford, United Kingdom), T. Leng (Oxford, United Kingdom), J. Matthews (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Willberg (Oxford, United Kingdom), A. Ramasamy (Oxford, United Kingdom), R. Djukanovic (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom). Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma. 4927

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005

CD8+ Tc2 cells: underappreciated contributors to severe asthma
Source: Eur Respir Rev, 28 (154) 190092; 10.1183/16000617.0092-2019
Year: 2019



High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004

CD4+CD25+ T lymphocytes in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004

Increased T helper lymphocytes and macrophages in peripheral airways of patients with uncontrolled asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


IL-10-producing CD4+ T cells are essential for the development of airway hyperresponsiveness
Source: Annual Congress 2004 - Modulation of the allergic response in animal models
Year: 2004


Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Characteristics of fatal asthma: CD8 positive T cells producing IFN-γ and IL-18 were recruited into small airways in fatal asthma
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


CMV- and EBV-specific CD8+ T cell responses in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

PAS-1, an Ascaris suum protein, modulates allergic airway inflammation via CD8+ and CD4+ CD25+ T cells
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



Reduced numbers of circulating CD4+CD25highFOXP3+ regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008


Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking
Source: Eur Respir J 2007; 29: 42-50
Year: 2007



LATE-BREAKING ABSTRACT: Increased cytotoxic T cells, CX3CR1+, γδ and IL17+ T cells in severe asthma during exacerbation
Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments
Year: 2012

Late-breaking abstract: Role of IL-13-producing BLT1-positive CD8 T cells in asthmatic airway obstruction
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011

Airway granzyme B from CD8+ T-cells is related to severity of airflow obstruction in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 673s
Year: 2006